Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International News In Brief

This article was originally published in The Gray Sheet

Executive Summary

European diagnostics directive: The European Commission is considering revising European regulations for in vitro diagnostic devices, and launched a public consultation June 29. The European IVD directive has not been substantially amended since it was adopted in 1998, the commission notes. The consultation is targeted to specific IVD issues, including whether adopting a risk-based classification system for diagnostics would improve the current regulatory framework; whether conformity assessments for diagnostics should be changed; whether tests should require more pre-market clinical evidence; and whether "in-house tests," which are made and used within the same health institution and not marketed elsewhere, should remain exempt from government oversight. Input on the IVD revision is due Sept. 15. Europe launched a public consultation on the recast of the Medical Devices Directives in 2008, with plans to address diagnostics separately (1"The Gray Sheet" June 1, 2009). The European Diagnostics Manufacturers Association supports the revision and held a July 2 workshop to discuss "how best to address the future of IVDs." European trade association Eucomed also says it is preparing comments on the consultation

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel